Place Preference in Neuropathic Rats Can Reflect Pain Relief, Not Just Reward

A preference for a drug-paired location needs to be interpreted in context. In rats with nerve-injury pain, a CBD-morphine combination produced place preference alongside antinociceptive effects. That finding is not automatically proof of either addiction or its absence.

The model addressed evoked and ongoing pain

Researchers used chronic constriction injury of the sciatic nerve and measured mechanical thresholds. They also used conditioned place preference as an indirect approach to relief of ongoing pain, examining whether rats favored a location associated with treatment.

The combination differed from either drug alone

The abstract reports enhanced antinociception when CBD was combined with a low morphine dose compared with that morphine dose alone. The combination produced significant place-preference findings, whereas the tested individual treatments did not. Locomotor activity did not change under the reported combination conditions.

The null findings do not identify one explanation

Absence of a locomotor change reduces one possible complication but does not prove why a location became preferred. Preference can reflect relief from an aversive state, rewarding drug effects or multiple processes. The experimental setting and comparison groups matter.

CBD also partially attenuated morphine tolerance in this study. Partial attenuation is different from preventing tolerance entirely. These results support further preclinical investigation, not a human recommendation to combine CBD with an opioid. The outcome definitions, injured-animal model and treatment conditions should accompany any account of the finding.

Related: interpreting cannabis tolerance claims.

Research cited

Jesus CHA; Ferreira MV; Gasparin AT; Rosa ES; Genaro K; Crippa JAS; Chichorro JG; Cunha JMD. Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model. Behavioural brain research (2022). doi:10.1016/j.bbr.2022.114076. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Why Blocking Endocannabinoid Breakdown May Affect More Than Cannabinoid Signaling

Inhibiting endocannabinoid breakdown is not necessarily equivalent to selectively activating a cannabinoid receptor. A 2014 pain-research review identified tolerance and pain-promoting prostamides as potential limits on the benefits of cannabinoid-hydrolyzing enzyme inhibitors. An enzyme intervention can change a signaling network Enzyme inhibition alters the handling of signaling molecules rather than…

Spread the love

Read Article: Why Blocking Endocannabinoid Breakdown May Affect More Than Cannabinoid Signaling

Synthetic Cannabinoid Reports and Animal Experiments Answer Different Toxicity Questions

Reports of reactions to synthetic cannabinoids and controlled animal experiments provide different kinds of toxicity evidence. A 2017 review of “Spice” combined those literatures while emphasizing methodological and exposure uncertainties. Their findings should not be merged into a single marijuana risk estimate. A reported human event can raise a safety…

Spread the love

Read Article: Synthetic Cannabinoid Reports and Animal Experiments Answer Different Toxicity Questions

Astroglial CB1 Findings After Electroacupuncture Are Not Evidence That THC Treats Stroke

A mouse study linked electroacupuncture-induced protection against cerebral ischemic injury to astroglial CB1 receptors. The intervention was electroacupuncture pretreatment, not THC. Receptor involvement therefore cannot be relabeled as evidence that marijuana treats stroke. The investigators examined a specific injury model The 2021 study used a middle cerebral artery occlusion model…

Spread the love

Read Article: Astroglial CB1 Findings After Electroacupuncture Are Not Evidence That THC Treats Stroke

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us